NVX-412, a New Oncology Drug Candidate, Induces S-Phase Arrest and DNA Damage in Cancer Cells in a p53-Independent Manner

Open Access

Peer-reviewed

Research Article

Alexandra Hebar,

Affiliation Department of Radiation Oncology, Medical University of Vienna, Vienna, Austria
⨯
Barbara C. Rütgen,

Affiliation Institute of Immunology, Department for Pathobiology, University of Veterinary Medicine Vienna, Vienna, Austria
⨯
Edgar Selzer

* E-mail: edgar.selzer@meduniwien.ac.at

Affiliation Department of Radiation Oncology, Medical University of Vienna, Vienna, Austria
⨯

Reader Comments (0)

DNA replication
Is the Subject Area "DNA replication" applicable to this article?

Thanks for your feedback.
DNA damage
Is the Subject Area "DNA damage" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Synthesis phase
Is the Subject Area "Synthesis phase" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Lymphoma
Is the Subject Area "Lymphoma" applicable to this article?

Thanks for your feedback.
Prostate cancer
Is the Subject Area "Prostate cancer" applicable to this article?

Thanks for your feedback.
Cell cycle and cell division
Is the Subject Area "Cell cycle and cell division" applicable to this article?

Thanks for your feedback.